English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

菊地 健三 ・平田 稔 ・今井 祥雄 ・荒蒔.義 知 * Methylhesperidin employed in this experiment consists of 46.5% of 3'-methyl-7-(rhamnosy-2-methyl glucosyl)-hesperetin, 25.2% of 3'-methyl-7-(2-methylrhamnosylglucosyl)-hesperetin and 19.8% of 3' monomethyl hesperidin. FIG. 1. Typical record showing the potentiation of coronary dilating action of 3'-AMP by methylhesperidin on a nembutalized, open-chest dog. BP: Blood pressure, CF: Left coronary blood flow, HR : Heart rate.

THE POTENTIATION OF THE CORONARY DILATING AND THE CARDIAC ACTION OF ADENOSINE OR ADENINE NUCLEOTIDES BY METHYLHESPERIDIN